orphan drugs

also referred to as: orphan drug

2 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Jun 1, 2020 by Clark Futch · across every show →

Everything said about orphan drugs, oldest first

Jun 1, 2020 bullish
Insight
Futch: Orphan drugs preserve pricing power because rare disease costs are negligible to insurers
“The drugs are very expensive, but it's a very small line item on any insurance plan as opposed to cholesterol or diabetes or things that affect millions and millions of patients. So your pricing power there is better and therefore makes it more attractive and …”
Clark Futch Jun 1, 2020 ▶ 37:46 Clarke Futch – Healthcare Royalty Partners (First Meeting, EP.20)
Jun 1, 2020
Assertion Supported
Futch: US Orphan Drug legislation grants seven years of market exclusivity
“In order to make it economically attractive, the government put in legislation that said if you do it, and you have to go through an FDA regulatory review, We will give you seven years of exclusivity where we will not approve another drug that does the same th…”
Clark Futch Jun 1, 2020 ▶ 36:56 Clarke Futch – Healthcare Royalty Partners (First Meeting, EP.20)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 700 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.